Vanguard Group Inc Roivant Sciences Ltd. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 39,326,336 shares of ROIV stock, worth $455 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,326,336

Previous 40,767,590 3.54%

Holding current value

$455 Million

Previous $411 Million 7.75%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$9.08 - $11.62 $13.1 Million - $16.7 Million	-1,441,254 Reduced 3.54%	39,326,336 $443 Million
Q1 2025 May 09, 2025	SELL	$10.09 - $12.08 $33.5 Million - $40.1 Million	-3,319,697 Reduced 7.53%	40,767,590 $411 Million
Q4 2024 Feb 11, 2025	BUY	$11.16 - $12.71 $26.8 Million - $30.6 Million	2,404,232 Added 5.77%	44,087,287 $522 Million
Q3 2024 Nov 13, 2024	BUY	$10.17 - $12.5 $341 Million - $419 Million	33,491,231 Added 408.84%	41,683,055 $481 Million
Q2 2024 Aug 13, 2024	BUY	$10.36 - $11.74 $885,697 - $1 Million	85,492 Added 1.05%	8,191,824 $86.6 Million
Q1 2024 May 10, 2024	BUY	$9.87 - $11.8 $10.2 Million - $12.2 Million	1,030,681 Added 14.57%	8,106,332 $85.4 Million
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $12.3 Million - $17.1 Million	1,473,085 Added 26.29%	7,075,651 $79.5 Million
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $33.6 Million - $45.4 Million	3,440,374 Added 159.12%	5,602,566 $65.4 Million
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $2.79 Million - $3.96 Million	393,350 Added 22.24%	2,162,192 $21.8 Million
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $830,005 - $1.2 Million	119,943 Added 7.27%	1,768,842 $13.1 Million
Q4 2022 Feb 10, 2023	BUY	$3.36 - $7.99 $253,088 - $601,838	75,324 Added 4.79%	1,648,899 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $29,185 - $276,973	57,226 Added 3.77%	1,573,575 $5.07 Million
Q2 2022 Aug 12, 2022	BUY	$2.81 - $4.84 $553,148 - $952,754	196,850 Added 14.92%	1,516,349 $6.17 Million
Q1 2022 May 13, 2022	BUY	$4.74 - $9.91 $757,390 - $1.58 Million	159,787 Added 13.78%	1,319,499 $6.52 Million
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $6.8 Million - $15.7 Million	1,159,712 New	1,159,712 $11.7 Million

Others Institutions Holding ROIV

# of Institutions

350

Shares Held

495M

Call Options Held

3.67M

Put Options Held

754K

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.15B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Roivant Sciences Ltd. Transaction History